Volume 5, Number 2 (Mar/Apr 2014)

The Launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO)

What is the Etiology of Dysarthria and Ataxia in a Woman With Cancer?

Celebrities and Medicine: A Potent Combination

Improving Surgical Outcomes in Pancreatic Surgery With Preoperative Nutrition

The purposes of this study were (1) to describe the relationship between preoperative physical status and postoperative outcomes in patients undergoing Whipple resection, and (2) to determine if the use of specialized immunonutrition wit...

Ado-Trastuzumab Emtansine in Metastatic HER2-Positive Breast Cancer

Calculating Your Worth: Understanding Productivity and Value

Advanced Practitioners in Oncology: Diverse Experiences, Shared Challenges

Leaders of ASCO, ASH, ASTRO, and NCCN Embrace Collaboration With Advanced Practitioners

Distress Screening in Chronic Disease: Essential for Cancer Survivors

Distress is a psychological state that is often observed in patients with chronic disease. Many cancers are considered chronic in nature, with patients experiencing long, disease-free states and intervals of metastatic disease. Distress ...

Information Needs Priorities in Patients Diagnosed With Cancer: A Systematic Review

Information-sharing is an integral part of cancer care. Several studies have examined the information needs of patients with various types of cancer. However, the priorities of information needs among patients with cancer have not been r...

Advanced Practitioners’ Favorite Books: The Sequel

JL01. The Role of the Multidisciplinary Tumor Board in the Management of Patient with Gastrointestinal Malignancy

The optimal evaluation and management of the patient with gastrointestinal (GI) malignancy is multimodal, involving coordination between multiple specialties, including radiology, pathology, medical oncology, surgical oncology, radiation...

JL02. Virtual Reality as an Adjunct Method to Alleviate Pain and Anxiety in Patients Undergoing Bone Marrow Procedures

Purpose: The purpose of this randomized controlled study is to determine the clinical feasibility of using virtual reality at the bedside with patients who are undergoing a bone marrow biopsy. Outcome measures included pre and post pain ...

JL03. Adding to Your Tool Box: Holistic Modalities

Significance: Holistic medicine, as defined by the American Holistic Medical Association, “is the art and science of healing that addresses care of the whole person—body, mind, and spirit.” The practice of holistic medicine integrates co...

JL04. Adjuvant Treatment With Toremifene in Hormone Receptor–Positive Breast Cancer: A Systematic Review of the Literature

Background: Endocrine therapy is an integral part of the backbone for hormone receptor–positive breast cancer treatment. Toremifene and tamoxifen are approved for hormone receptor–positive metastatic breast cancer. Tamoxifen is also appr...

JL05. Efficacy and Safety of the Granisetron Transdermal System (GTS) in Elderly Patients Receiving Multiday Chemotherapy Regimens

Background: Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of multiday chemotherapy that can lead to poor adherence, decreased quality of life, and compromised functional status. Commonly used routes of administr...

JL06. Hereditary Hemochromatosis: What the Nurse Practitioner Needs to Know

Background: Hereditary hemochromatosis is a disorder in which excessive iron absorption occurs, leading to an increase in iron deposits in major organs of the body and resulting in end organ damage. This is the most common genetic disord...

JL07. Intravenous Thiotepa for Meningeal Relapse of Breast Cancer: A Case Study

Treatment of meningeal carcinomatosis among breast cancer patients remains a clinical challenge, with a dismal outlook for long-term survival. Intrathecal thiotepa administration has been described in the literature; however, there are p...

JL08. Merkel Cell Carcinoma: Is It on Your Differential?

Background: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine cutaneous malignancy with an atypical presentation, associated with the merkel cell polyomavirus (MCPyV) in 80% to 90% of cases. The vowel mnemonic, AEIOU is represe...

JL09. Personalized Medicine for Breast Cancer

Breast cancer is a biologically complex disease and remains one of the leading causes of cancer-related deaths in the world. Recent advances in genomic profiling of breast cancer tumors show promise in improving the outcomes of breast ca...

JL10. Subcutaneous Administration of Bortezomib: A Pilot Survey of Oncology Nurses

Background: The subcutaneous (SC) route of administration for bortezomib was approved in the United  States in January 2012 in addition to the intravenous (IV) route. Although there is limited guidance in the US Prescribing Information r...

JL11. Don’t Fall for It! Preventing Falls in Patients with Cancer

The Oncology Nursing Society’s 2009–2013 research agenda highlights the need for greater attention to impaired physical functioning in inpatients with cancer because of the significant physical, psychological, and economic consequences. ...

JL12. Management of Lenalidomide-Associated Cytopenias in Myelodysplastic Syndromes: Practical Take-Aways From Clinical Trials

Lenalidomide (LEN) is an oral immunomodulatory medication approved for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-1‒risk myelodysplastic syndromes (MDS) with del(5q). In clinical trials of LEN...

JL13. Practical Guide to Management of Lenalidomide-Related Rash in Patients With MDS

Lenalidomide (LEN) is an oral immunomodulatory medication approved for patients with lower-risk, transfusion-dependent myelodysplastic syndromes (MDS) with del(5q) with or without additional cytogenetic abnormalities. The goal of LEN tre...

JL14. Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes

Over 10,000 individuals are diagnosed with myelodysplastic syndromes (MDS) annually in the United States. Bone marrow (BM) examination is essential for diagnosis, classification, and risk-stratification of MDS. The World Health Organizat...